Skip to content

The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery

The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery,A Randomized Controlled Study

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02123355
Enrollment
80
Registered
2014-04-25
Start date
2014-08-31
Completion date
2014-08-31
Last updated
2014-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injury, Cognitive Ability, General

Brief summary

The incidence of postoperative cognitive dysfunction (POCD) is high and POCD affect the life quality and the prognosis of patients. Geriatrics is the independent risk factor of POCD, and POCD is also correlated with many other factors such as type of surgery, the duration of anesthesia and the anesthesia drugs used et al. So, the prevention and treatment of POCD in geriatrics is important. Dexmedetomidine is found to have the effect of neuro-protection, but it is controversy whether Dexmedetomidine has the effect of neuro-protection in geriatrics, especially the prolonged surgery. The purpose of this study is to explore the effect of Dexmedetomidine to the cognitive function at prolonged surgery in geriatrics in geriatrics.

Interventions

DRUGInduction of anesthesia

Midazolam 0.05 mg/kg、Propofol 1.0 mg/kg、Sufentanyl 3μg/kg、Victracurium 0.1 mg/kg sequential intravenous injection

PROCEDUREIntubation

After muscle relaxed and loss of eyelash reflex of the patients, intubation is done,then mechanical ventilation is performed, and maintain the PETCO2于35\ 40 mmHg,pulse oxygen saturation is more than 95%.

DRUGSevoflurane, remifentanil ,vecuronium

Sevoflurane(1%-2%)is inspirated, and remifentanil 0.1-0.5μg/kg//min is continuously pumped,vecuronium 0.03 mg/kg is injected intermittently.

DRUGDexmedetomidine

Dexmedetomidine is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

DRUGPlacebo

Normal saline is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Sponsors

Chinese Medical Association
CollaboratorNETWORK
Shaanxi Provincial People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Written informed consent 2. Scheduled for elective abdominal surgery 3. Age≥65 yrs 4. Weight is within the range of ±20% of standard weight \[standard weight=Height(cm)-80)×70﹪ for male and(Height(cm)-70)×60﹪\] for female 5. American society of anesthesia classification I\ III 6. Expected time of surgery is more than 4 hours -

Exclusion criteria

1. Systolic blood pressure≥180 mm Hg or \<90 mm Hg,diastolic blood pressure≥110 mm Hg or \< 60 mm Hg; 2. Serious cardiac,liver,kidney,lung, endocrine disease or sepsis. 3. Allergy to trial drug or other contraindication; 4. Difficult airway occurred before,or difficult airway possibly occurred and difficult to extubation 5. History of mental illness and cerebral vascular disease 6. History of unstable angina or myocardial infarction 7. Education level\<7 yrs 8. Factors existed that affect cognition assessment such as language, visual sense,auditory sense disorders. 9. Abuse of narcotic analgesia or suspected; 10. Neuromuscular diseases; 11. Mentally unstable or has a mental illness; 12. Pregnant or breast-feeding women; 13. Attended other trial past 30 days; -

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in cognitive function at 7 daysBaseline, the 7th day after the surgery1. Modified Newman scale to assess the cognitive function, including five tests. 2. The quiet environment, enough daylight, no disturb is needed when the modified Newman scale is done. All the five tests are finished within 30 min. 3. all the score of each test of all the patients assessed before the surgery is calculated, then get the standard variation, the score of each subject of each test is compared with the standard deviation, if one or more stand deviation decrease, then the cognitive function is considered as deterioration . 4. When 2 or more of the tests is considered as deterioration, then the patients is diagnosed as Post Operation Cognitive Dysfunction (POCD).

Secondary

MeasureTime frameDescription
Inflammatory responsive assessmentFrom entering the operating room to 48 hours after the surgery1. 2 ml blood sample is collected at 8 time points including before surgery,the right moment,2 hr and 4 hr after the induction, the right moment,12,24 and 48 hours after the surgery. 2. The concentration of protein S100B(S100B)and neuron specific enolase (NSE)in serum is tested using immunohistochemical double antibody sandwich enzyme-linked immunosorbent assay (ELISA).
Heart rateFrom the induction of anesthesia to the right moment of extubation, up to 1 day.Heart rate are monitored every 15 min from the induction of anesthesia to the right moment of extubation.
Depth of anesthesiaFrom the induction of anesthesia to the right moment of extubation, up to 1 day.Bispectral index(BIS) monitor are performed every 15 min from the induction of anesthesia to the right moment of extubation.
Recovery of anesthesiaFrom the induction of anesthesia to the right moment of extubation, up to 1 day.Time of anesthetic ceased,time of call to open eyes,time to extubation, time to leave the PACU are recorded.
Brain injury assessmentFrom entering the operating room to 48 hours after the surgery1. 2 ml blood sample is collected at 8 time points including before surgery,the right moment,2 hr and 4 hr after the induction, the right moment,12,24 and 48 hours after the surgery. 2. The serum level of C-reaction protein(CRP),tumor necrosis factor(TNF-α)、interleukin-6(IL-6),interleukin-10(IL-10) is tested using immunohistochemical double antibody sandwich enzyme-linked immunosorbent assay (ELISA)
Blood pressureFrom the induction of anesthesia to the right moment of extubation, up to 1 day.systolic blood pressure, Diastolic blood pressure are monitored every 15 min from the induction of anesthesia to the right moment of extubation.
Respiration rateFrom the induction of anesthesia to the right moment of extubation, up to 1 day.Respiration rate are monitored every 15 min from the induction of anesthesia to the right moment of extubation.
Pulse blood oxygen saturationFrom the induction of anesthesia to the right moment of extubation, up to 1 day.Pulse blood oxygen saturation are monitored every 15 min from the induction of anesthesia to the right moment of extubation.
Number of Participants with Serious and Non-Serious Adverse EventsUp to 7 days
Central venous pressure(CVP)From the induction of anesthesia to the right moment of extubation, up to 1 day.Central venous pressure(CVP) are monitored every 15 min from the induction of anesthesia to the right moment of extubation.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026